Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC.

R.H. Medema, C.C. Lin, J.C. Yang

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)6459-6466
Number of pages8
JournalClinical Cancer Research
Volume17
Issue number20
Publication statusPublished - 2011

Cite this